top of page

The Cancer Investor Conference 

This highly exclusive conference will feature a global update on progress in oncology.  This conference will provide an intimate setting for investors to meet with the management of a highly screened group of companies and key opinion leaders in the field of oncology.

Sponsored by OneMedMarket and MediaWerks and will be held June 27 and 28th in New York City at the New York Stem Cell Foundation.  

Sessions on Artificial intelligence and new Financial Models will offer insights into dramatic changes and opportunities that on horizon.

It will present the latest developments in oncology and a select group of exceptional investment opportunities immunotherapy, diagnostics, and therapeutic interventions.  Key opinion leaders in the field of oncology, as well as life science investors  will lead discussions on challenges and opportunities in oncology: Event Sponsors 

  • The National Foundation for Cancer Research

  • International Cancer Impact Fund

  • The Altru Institute

  • Venable LLP 

Conference delegates will gain access tot the Global Database Cancer innovations.  The objective is enable investors to understand the highest and best use of capital in the oncology space. 


Participating companies will have access to a video production suite at the conference will to produce high quality management videos that appear in company profiles in the database and accessible to investors globally unable to attend.

All companies active in this area interested in appearing in this focused Investment Guide should contact Bob Trehy for details at

For information or to apply to attend or present at this conference: 


This event is focused on connecting impact investors with select growth companies that present best impact investment opportunities in Oncology.

Contact us for more information at



If you are an active impact investors and would like to receive additional information complete our short survey

bottom of page